The ␤ isoform of thyroid hormone receptor (TR-␤) has a key role in the feedback regulation of the hypothalamic-pituitary-thyroid (H-P-T) axis. The mechanism of trans-repression of the hypothalamic thyrotropin-releasing hormone (TRH) and pituitary thyroid-stimulating hormone (TSH) subunit genes, however, remains poorly understood. A number of distinct mechanisms for TR-␤-mediated negative regulation by thyroid hormone have been proposed, including those that require and do not require DNA binding. To clarify the importance of DNA binding in negative regulation, we constructed a DNA-binding mutant of TR-␤ in which two amino acids within the P box were altered (GSG for EGG) to resemble that found in the glucocorticoid receptor (GR). We termed this mutant GS125, and as expected, it displayed low binding affinities for positive and negative thyroid hormone-response element (pTRE and nTRE, respectively) in gel-mobility shift assays. In transient transfection assays, the GS125 mutant abolished transactivation on three classic pTREs (DR؉4, LAP, and PAL) and all negatively regulated promoters in the H-P-T axis (TRH, TSH-␤, and TSH-␣). However, GS125 TR-␤ bound to a composite TR/GR-response element and was fully functional on this hybrid TR/GR-response element. Moreover, the GS125 TR-␤ mutant displayed normal interactions with transcriptional cofactors in mammalian twohybrid assays. These data do not support a DNA-binding independent mechanism for thyroid hormone negative regulation in the H-P-T axis.
The ␤ isoform of thyroid hormone receptor (TR-␤) has a key role in the feedback regulation of the hypothalamic-pituitary-thyroid (H-P-T) axis. The mechanism of trans-repression of the hypothalamic thyrotropin-releasing hormone (TRH) and pituitary thyroid-stimulating hormone (TSH) subunit genes, however, remains poorly understood. A number of distinct mechanisms for TR-␤-mediated negative regulation by thyroid hormone have been proposed, including those that require and do not require DNA binding. To clarify the importance of DNA binding in negative regulation, we constructed a DNA-binding mutant of TR-␤ in which two amino acids within the P box were altered (GSG for EGG) to resemble that found in the glucocorticoid receptor (GR). We termed this mutant GS125, and as expected, it displayed low binding affinities for positive and negative thyroid hormone-response element (pTRE and nTRE, respectively) in gel-mobility shift assays. In transient transfection assays, the GS125 mutant abolished transactivation on three classic pTREs (DR؉4, LAP, and PAL) and all negatively regulated promoters in the H-P-T axis (TRH, TSH-␤, and TSH-␣). However, GS125 TR-␤ bound to a composite TR/GR-response element and was fully functional on this hybrid TR/GR-response element. Moreover, the GS125 TR-␤ mutant displayed normal interactions with transcriptional cofactors in mammalian twohybrid assays. These data do not support a DNA-binding independent mechanism for thyroid hormone negative regulation in the H-P-T axis.
The synthesis and secretion of thyroid hormones are exquisitely regulated by a negative feedback system that involves the hypothalamus, pituitary, and thyroid gland (the hypothalamicpituitary-thyroid axis: H-P-T axis). 1 The synthesis of thyrotropin-releasing hormone (TRH), produced in the paraventricular nucleus of the hypothalamus, and the ␣ and ␤ subunits of thyrotropin (thyroid-stimulating hormone; TSH) in the anterior lobe of the pituitary is inhibited at the transcriptional level by thyroid hormone (T 3 ) (1) (2) (3) (4) . Negative regulation of gene expression by T 3 is an integral part of the function in the H-P-T axis, and these effects are mediated by the ␤ isoform of the thyroid hormone receptors (TR-␤). Of the ␤ isoforms, TR-␤2 is quantitatively and functionally more important than TR-␤1 in regulating the hypothalamus and pituitary (5) (6) (7) (8) . The molecular mechanisms responsible for TR-mediated negative regulation of target genes are not well understood.
In the traditional model of TR action, TR regulates gene expression by binding to specific thyroid hormone-response elements (TRE) on target genes. A number of artificial and natural positive thyroid hormone-response elements (pTREs) have been described, and they can be classified based on the half-site arrangement in the element: DRϩ4, PAL, and LAP (LYS) (9 -11) . On target genes negatively regulated by T 3 , response elements (nTREs) have been described in the TRH and TSH-␤ subunit genes (12) (13) (14) (15) (16) (17) . In these nTREs, TR bound as a monomer to widely spaced half-sites or in the case of TRH with retinoid X receptor (RXR) to an unusual element (13, 18 -20) . Mutagenesis studies (21, 22) suggest that TR DNA binding to the half-site is required for negative regulation. Activation of these nTRE in the absence of T 3 is mediated by the N terminus of TR-␤2 via a mechanism involving binding of coactivator proteins (23, 24) .
In contrast, some investigators have suggested that TR DNA binding is not required for negative regulation. This mechanism has been proposed to explain negative regulation of the TSH-␣ promoter where an nTRE has not been clearly identified (25, 26) . In this model, corepressors bind to TR in solution and activate gene expression; in the presence of T 3 , corepressors dissociate from the TR and return to the TSH-␣ promoter to repress gene expression. A major concern in this model, however, is how specificity of negative regulation is achieved in the absence of DNA binding. Thus, both on and off DNA binding mechanisms have been proposed to explain negative regulation by thyroid hormone.
TRs, like other members of the superfamily of nuclear hormone receptors, have a conserved protein structure including a central DNA binding domain (DBD) and a C-terminal ligand binding domain (27, 28) . The DBD is composed of two zinc finger motifs in which the zinc ion is tetrahedrally coordinated by four cysteines (29, 30) . C-terminal to each zinc finger is an amphipathic ␣-helix. The ␣-helix of the first finger motif is responsible for sequence-specific DNA recognition, whereas the ␣-helix following the second finger motif provides phosphate contacts to the DNA and stabilizes the structure (31) . The central two nucleotides of the hexameric half-site consensus motif (AGNNCA) in a hormone-response element is determined by three receptor-specific amino acids in the DNA recognition ␣-helix, referred to as the P box (32) . Nuclear receptors have * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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been divided into two subfamilies according to the identity of their P box amino acid sequences (33) . The subfamily of glucocorticoid receptor (GR) has a GSV (glycine-serine-valine) P box sequence and is able to bind to DNA elements containing the nucleotide sequence of AGAACA. The subfamily that includes the TRs has a more diverse P box sequence. TRs contain an EGG (glutamic acid-glycine-glycine) P box sequence and recognize DNA elements with the nucleotide sequence of AG-GTCA (Fig. 1 ).
Within the P box, the first two amino acids are most important in defining binding to a DNA-response element. Therefore, based on the differences between the P box of GR and TR, we constructed a P box mutant that substituted the first two amino acids in TR with the first two amino acids of GR (EGG to GSG) (Fig. 1) . The GS125 TR-␤ mutant had markedly impaired function on both positive and negative TRE due to disrupted DNA binding. However, this unique DBD mutant was fully functional when tested on a composite TR/GR DNA response element. We demonstrate, therefore, that DNA binding by TR-␤ is required on all nTREs known to regulate the H-P-T axis.
MATERIALS AND METHODS
Plasmid Constructions-Point mutations in the thyroid hormone receptor ␤ were constructed by site-directed mutagenesis in the context of the TR-␤2 isoform. GS125 mutant TR-␤2 cDNA was inserted into the pKCR2 (pSG5) expression vector at an EcoRI site; wild type TR-␤1 and TR-␤2 were constructed in a similar way and have been described previously (34, 35) . The construction of thyroid hormone-responsive luciferase reporter genes (DRϩ4-TKLuc, LAP-TKLuc, and PAL-TKLuc) has been reported previously (23) . Negatively regulated gene promoters in the identical luciferase reporter (pA3Luc) have also been described: human TRH Ϫ900 to ϩ55, human TSH-␣ Ϫ846 to ϩ44, and human TSH-␤ Ϫ1192 to ϩ37 bp (36) . The hybrid TR/GRE 3, as two copies, was inserted upstream of TK 109 in pA3Luc. The GAL4 reporter plasmid UAS-TK-Luc contains two copies of the GAL4 recognition sequences upstream of TK109 in pA3Luc. Construction of nuclear receptor corepressor (NCoR), steroid receptor coactivator-1 (SRC-1), and RXR-␣ Gal4BD fusion expression vectors was described previously (37) . The VP16AD-GS125 mutant TR-␤2 was created by exchanging appropriate restriction fragments within the VP16AD-TR-␤2 construct, which has been reported previously (38) .
Electrophoretic Mobility Shift Assay-The oligonucleotide sequences of DRϩ4 and TRH site 4 probe were reported previously (13, 37) . Hybrid TR/GR-response elements, TR/GRE 1, 2, and 3-DRϩ4 were designed to contain an intact 5Ј half-site and a mutant 3Ј half-site separated by a four-nucleotide gap. This strategy was based on polarity studies of the DRϩ4 element where it has been shown that RXR binds to the 5Ј and TR binds to the 3Ј half-sites in a DRϩ4 (39, 40) . Wild type or mutant TRs were transcribed/translated in vitro in reticulocyte lysate (Promega Corp., Madison WI) using T7 polymerase. To quantify protein production, 35 S incorporation and direct visualization on SDS-PAGE were used. Four l of TR-␤ and 2 l of in vitro translated RXR-␣ or an equivalent amount of unprogrammed lysate were used in each reaction with 32 P-radiolabeled probe. Binding reactions were performed in 20 l of binding buffer containing 20% glycerol, 20 mM HEPES, pH 7.6, 50 mM KCl, 1 mM dithiothreitol, 1 g of poly(dI-dC), and 0.1 g of salmon sperm DNA at room temperature for 20 min. The protein-DNA complexes were resolved on 5% nondenaturing polyacrylamide gels and visualized after autoradiography.
Western Blot Analysis-Whole cell extracts were prepared with RIPA Buffer (41) including 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 40 l/ml Protease Inhibitor Mixture (Roche Molecular Biochemicals). Proteins were resolved by SDS-PAGE and transferred onto nitrocellulose transfer membranes (Protran; Schleicher & Schuell, Keene, NH). Immunodetection was performed using mouse monoclonal TR-␤ antibody (MA1-215; Affinity Bioreagents, Golden, CO) and antimouse, horseradish peroxidase-conjugated IgG (Amersham Biosciences). Protein bands were visualized using ECL-Plus kit (Amersham Biosciences) according to the manufacturer's instructions.
Avidin-Biotin Complex DNA Binding (ABCD) Assay-Whole cell extracts from GH 3 cells or transfected 293T cells were incubated with 3 g of biotinylated double-stranded DNA at 4°C for 4 h with constant rotation. Sense and antisense TRE oligonucleotides were 5Ј-biotinylated as follows: rGH sense (5Ј-ttt cgg tgg aaa ggt aag atc agg gac gtg acc gca gga gag caa a-) and antisense (5Ј-ttt gct ctc ctg cgg tca cgt ccc tga tct tac ctt tcc acc gaa a-); hTSH-␤ sense (5Ј-ttt ttt ggg tca cca cag cat ctg ctc acc aat gca aag taa gaa a-) and antisense (5Ј-ttt ctt act ttg cat tgg tga gca aga tgc tgt ggt gac cca aaa aa-); and mutated hTSH-␤ sense (5Ј-ttt ttt ttt tca cca cag cat ctg ctc acc aat gca aag taa gaa a-) and antisense (5Ј-ttt ctt act ttg cat tgg tga gca aga tgc tgt ggt gaa aaa aaa aa-). The DNA-protein suspensions were precipitated with streptavidin-agarose (Invitrogen) for 1 h, washed with RIPA Buffer, and re-precipitated by centrifugation. The bound materials were eluted and separated with boiling and brief centrifugation and then resolved by SDS-PAGE. Western blot analysis was performed as described previously (41) .
ChIP Assays-ChIP assays were performed essentially as described previously (42) with the following modifications. 293T cells were transfected with 10 g of hTSH-␣ pA3Luc or TK 109 in pA3Luc and 5 g of either TR-␤2 or GS125 mutant TR-␤2 pKCR2 using the calcium phosphate method. After no treatment or treatment with 10 nM T 3 , formaldehyde was added at 1% to culture medium, and cells were incubated for 10 min at 37°C to cross-link proteins to the transfected promoter plasmids. Cells were collected and resuspended in 200 l of SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1) with 1 mM phenylmethylsulfonyl fluoride and protease inhibitors. Lysates were cleared by centrifugation and diluted 10-fold with dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl). 10% of the lysate was kept to quantitate the amount of DNA present in different samples at the PCR analysis as an input. After pre-clearing with a salmon sperm DNA/protein A-agarose/50% slurry (Upstate Biotechnology, Lake Placid, NY), immunoprecipitation with a TR-␤ antibody (MA1-215; Affinity Bioreagents) was performed at 4°C overnight. Immunoprecipitated complexes were collected by salmon sperm DNA/protein A-agarose and followed by sequential washes in low salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), high salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 500 mM NaCl), LiCl immune complex wash buffer (0.25 M LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1), and TE buffer. Precipitates were eluted with elution buffer (1% SDS, 0.1 M NaHCO 3 ), and 5 M NaCl was added to reverse cross-links at 65°C for 4 h. DNA was recovered by phenol/chloroform extraction and ethanol precipitation. Pellets were resuspended in TE buffer and subjected to PCR using specific 5Ј primers for the hTSH-␣ pA3Luc (5Ј-caa agt gac agc gta ctc tct t) or TK 109 pA3Luc (5Ј-ccg ccc agc gtc ttg tca tt) and a common 3Ј luciferase primer (5Ј-cta gag gat aga atg gcg ccg ggc ctt tct).
Cell Culture and Transient Transfection Assay-293T cells were maintained in Dulbecco's modified Eagle's medium supplemented with L-glutamine, 10% fetal calf serum, 100 g/ml penicillin, 0.25 g/ml streptomycin, and amphotericin. Transient transfections were performed in subconfluent 6-well plates on subconfluent cells; 1.7 g of The GR and thyroid hormone receptor ␤ P box sequence and their consensus DNA-binding half-sites are shown in the lower half of the figure. The first two amino acids of the GS125 mutation correspond to the P box of GR, whereas the third amino acid corresponds to that of TR.
reporter construct with 0.1 g of receptor expression vector or 0.1 g of pKCR2 vector alone were added to each well using the calcium phosphate technique. 12-15 h after transfection the cells were washed with PBS, and culture medium containing fetal bovine serum treated with anion exchange resin (type AGX-8, analytical grade; Bio-Rad) was added. Twenty four hours after transfection, 10 nM T 3 was added, and 42-48 h after transfection culture were harvested and assayed for luciferase activity. Mammalian two-hybrid assays were performed also using the calcium phosphate technique in 6-well plates, with each well receiving 1.7 g of upstream activating sequence (UAS)-TK luciferase reporter, 0.1 g of Gal4DBD-SRC-1 NBD, Gal4DBD-NcoR, or Gal4DBD-RXR and 0.1 g of VP16-TR-␤1, -TR-␤2, or VP16-GS125 mutant TR-␤2.
RESULTS
The DNA Binding Affinity of the GS125 TR-␤ Is Reduced on Both Positive TRE and Negative TREs-Recent cell culture and TR knockout model studies suggest that the ␤2 isoform of the thyroid hormone receptor (TR-␤2) plays the predominant role in the feedback regulation of the H-P-T axis (43) (44) (45) . Therefore, we introduced the GS125 mutation into the TR-␤2 isoform and used it for the following experiments. To assess the DNA binding property of the GS125 mutant, in vitro translated protein was analyzed by gel-shift studies using various radiolabeled TRE probes. A DRϩ4 probe was employed as a pTRE and a TRH site 4 probe was utilized as a nTRE. The site 4 sequence from human TRH promoter is a well established nTRE (13) . As shown in Fig. 2 , wild type TR-␤1 and TR-␤2 bound to either the DRϩ4 or TRH site 4 probe as both a homodimer and as a heterodimer with RXR. In contrast the GS125 mutant was unable to bind to either element in the absence or presence of RXR. In data not shown, weak binding of the GS125 mutant to a DRϩ4 probe was noted if the gel-shift study was performed at 4°C, but the corresponding wild type TRs also had markedly increasing binding. Thus, the GS125 mutation displayed significantly reduced affinities for both positive and negative TREs.
To demonstrate direct interaction of TR-␤ to the negative TRE in vivo, a modified avidin-biotin complex DNA binding (ABCD) assay was employed with non-transfected GH 3 cells (Fig. 3) . 5Ј-Biotinylated double-stranded DNA fragments containing either a rat GH pTRE, a human TSH-␤ nTRE, or mutated human TSH-␤ TRE were incubated with whole cell extracts from GH 3 cells in the presence or absence of T 3 (21, 47) . Bound proteins were precipitated with streptavidin-agarose and tested by Western blot analysis using a specific TR-␤ antibody. TR-␤ was equally recruited to naturally occurring pTRE and nTRE in the absence or the presence of T 3 . In the control experiment, a mutation in the human TSH-␤ nTRE abrogated TR-␤ binding (Fig. 3C) . These data clearly demonstrated that DNA binding of TR-␤ was DNA-dependent on negative as well as on positive TREs. Next, the DNA-binding affinity of the GS125 TR-␤2 mutant was evaluated using whole cell extracts from transfected 293T cells. Results in Fig. 3D show that transfected TR-␤2 bound to the biotinylated positive and negative TRE in a ligand-independent manner. On the other hand, GS125 TR-␤2 binding to the positive and negative TRE was almost undetectable, which is consistent with the results observed in gel-shift analysis.
Because a putative site on the TSH-␣ promoter for TR binding has not been identified, the interaction of TR-␤ with the TSH-␣ promoter was investigated using a modified chromatin immunoprecipitation (ChIP) assay in transfected 293T cells (Fig. 3E) . In this procedure, DNA is cross-linked, isolated, and subjected to immunoprecipitation with an antibody against a specific protein. By using a TR-␤ antibody, association of TR-␤ with TSH-␣ promoter was analyzed by PCR with specific primers for the TSH-␣ promoter. For these experiments, the human 
FIG. 3. DNA binding to TREs in an ABCD assay and modified ChIP assay. A, diagram of a modified avidin-biotin complex DNA binding assay (ABCD assay). B, TRE sequences used in the assay.
Positive TRE (rGH; Ϫ198 to Ϫ158), negative TRE (hTSH-␤; Ϫ3 to ϩ37), and mutated nTRE (mut. hTSH-␤) were 5Ј-biotinylated. Arrows indicate the position and orientation of half-sites. ABCD assay was performed using whole cell extracts (WCE) from non-transfected GH 3 cells (C) and transfected 293T cells (D). Whole cell extracts were incubated with double-stranded biotinylated pTRE, nTRE, or mutated nTRE in the presence or absence of T 3 . TR-␤ was detected by Western blot analysis using an anti-TR-␤ antibody. Whole cell extract was applied to the input lane before performing the binding reaction to demonstrate the location of the TR-␤ protein. Negative control (NC) was eluted after the same reaction without adding any biotinylated oligonucleotides. E, ChIP assays of promoters cotransfected with TR-␤2 or GS125 TR-␤2 in 293T cells. Arrows indicate the PCR primers used to analyze ChIP samples for human TSH-␣ promoter in the left panel or a TK promoter as a control in the right panel. Cell lysates were immunoprecipitated with TR-␤ antibody except negative control (NC) using nonspecific antibody. Input was used to determine total transfected promoter DNA by PCR in the same PCR procedure with ChIP samples.
TSH-␣ promoter pA3Luc plasmid was cotransfected into 293T cells with either TR-␤2 or GS125 mutant TR-␤2, and a PCR for the presence of the hTSH-␣ promoter was performed. As demonstrated in the left panel, transfected TR-␤2 interacted equally well with the TSH-␣ promoter in the absence or presence of T 3 . As a control experiment, TK 109 pA3Luc plasmid was transfected and immunoprecipitated with the same procedure, and a PCR for the TK promoter was performed. As shown in the right panel, no bands were detected from samples immunoprecipitated with TR-␤ antibody. In addition, a nonspecific antibody did not precipitate the hTSH-␣ promoter sequences with transfected wild type TR-␤ (NC, Fig. 3E) . These results clearly demonstrate that TR-␤2 associated specifically with the TSH-␣ promoter in cell culture. By contrast, transfected GS125 TR-␤2 binding to the hTSH-␣ promoter in 293T cells was almost undetectable. Thus, it is clear that the GS125 mutation disrupted the ability of TR-␤ to bind to negative thyroid hormone-response elements.
A DBD Mutant of TR-␤2 Is Defective on Positive and Negative TREs-Ligand-dependent transcriptional activation by the GS125 mutant TR was examined in transient transfection assays in 293T cells using three different pTREs as reporter constructs. As demonstrated in Fig. 4A , cotransfection of wild type TR-␤2 increased DRϩ4 TK-Luc activity by 23-fold after treatment with T 3 . Interestingly, cotransfection of RXR-␣ significantly reduced T 3 -mediated activation on this reporter. In contrast, T 3 stimulation of this same reporter was not observed with GS125 TR-␤2 regardless of whether RXR-␣ was cotransfected. Similar results were obtained with the other pTREs: LAP-TKLuc (Fig. 4B ) and PAL-TKLuc (Fig. 4C) reporters. The GS125 DBD mutant, therefore, completely abolished T 3 -dependent transactivation of TR-␤2 on pTREs.
To determine whether negative regulation by T 3 required TR DNA binding, wild type or GS125 mutant TR-␤2 plasmids were cotransfected into 293T cells with each of the three negatively regulated gene promoters, TRH-Luc, TSH-␤Luc, and TSH␣Luc, and a control promoter, TK109 (Fig. 5 ). After treatment with T 3 , wild type TR-␤2 suppressed these negatively regulated gene promoter activities to ϳ40% of basal activities, whereas activity from the control reporter was not significantly changed. Moreover, RXR-␣ cotransfection did not significantly increase negative regulation by T 3 . However, the GS125 mutant TR-␤2, which lacks DNA-binding activity, paradoxically increased activity by 10 -20%. Cotransfection of RXR-␣ did not alter these results. The reduction in transactivation and transcriptional repression was not related to the quantity or stability of the mutant TR-␤2 protein in tissue culture, as the mutant receptor accumulated to a level similar to the wild type receptor as demonstrated by Western blot analysis of nuclear extracts prepared from transfected 293T cells (Fig. 5A) . Thus, the GS125 DBD mutant has no measurable repressive function on negatively regulated genes.
The GS125 DBD Mutant Is Functional on a Composite TR/ GR-response Element-To demonstrate that the GS125 TR-␤2 is a functional nuclear hormone receptor, we wished to determine whether it had activity on a natural or hybrid thyroid hormone-response element. Because the first two amino acids of the P box in GS125 TR-␤2 resemble those found in the GR, we tested its function on a naturally occurring glucocorticoid receptor element (GRE), mouse mammary tumor virus promoter in 293T cells. After treatment with T 3 , the GS125 mutant was unable to activate the mouse mammary tumor virus promoter (data not shown). Next, the GS125 mutant TR-␤2 was tested for DNA binding on hybrid TR/GR-response elements. Hybrid TR/GREs contained mutations of the third and fourth nucleotides of the downstream half-site hexamer, as shown in Fig. 6B , whereas the upstream TRE half-site and the direct repeat motif with four-nucleotide gap spacing were preserved for binding of heterodimeric partner, RXR. As shown in Fig. 6A , wild type TR-␤2 and GS125 TR-␤2 were able to bind to all three hybrid TR/GRE elements as heterodimers with RXR-␣. For the most part, GS125 TR-␤2 was able to bind to the hybrid TR/GRE 3 with much higher affinity than that of the wild type TR-␤2, and this element was chosen for further analysis.
A composite TR/GR-response element 3 (AGGTCA cagg AGAACA) was inserted as two copies into the TK-Luc reporter plasmid, and the transcriptional activity of the GS125 TR-␤2 was tested on this reporter in 293T cells with and without cotransfected RXR-␣ (Fig. 6C) . The GS125 mutant in the presence of T 3 was very active on this element, whereas wild type TR-␤2 showed an insignificant increase. Moreover, the transcriptional activation of GS125 TR-␤2 was significantly increased after cotransfection with RXR-␣, suggesting that binding of GS125 TR-␤2 was enhanced in the presence of cotransfected RXR-␣. These data indicate that the GS125 DBD mutant was expressed in the nucleus and acted as a functional TR on the composite TR/GR-response element. The GS125 DNA-binding Mutant Can Interact with Transcriptional Cofactors-To characterize the GS125 mutant function further, interactions between GS125 TR-␤2 and transcriptional corepressors and coactivators were examined in a mammalian two-hybrid assay. Gal4DBD-NcoR and -SRC-1, which contain their respective nuclear hormone receptor interaction domains, were tested for their ability to interact with wild type and GS125 mutant TR-␤2 (Fig. 7) . Nuclear corepressor protein (NCoR) mediates ligand-independent repression of TRs by forming a complex with histone deacetylase activities in the absence of ligand (48) . Gal4-NCoR interacts with VP16-TR-␤1 and VP16-TR-␤2 fusion proteins in the absence of T 3 , resulting in a 5-6-fold activation of the UAS-TK-Luc reporter. In the presence of T 3 , Gal4-NCoR dissociated from VP16-TRs and as a result the activity of UAS-TK-Luc was reduced to basal levels. Cotransfection of VP16-GS125TR-␤2 led to the same results as found with both isoform of wild type TR-␤, indicating that the mutant interacted normally with NCoR.
In the presence of T 3 , SRC-1 associates with TRs and mediates ligand-dependent transcriptional activation by TRs. In the presence of T 3 , a VP-16 fusion of the TR-␤ induced activity of UAS-TK-Luc by bound Gal4-SRC-1 by 6 -8-fold. Again the GS125 mutant TR-␤2 displayed an equivalent interaction as compared with wild type TR-␤2. Finally, the heterodimerization property of GS125 was examined with this assay. Coexpression of Gal4-RXR-␣ and VP16-TR-␤s resulted in a significant increase in reporter gene activity and the addition of T 3 , enhancing activities by 5-7-fold; equivalent results were observed with the mutant. These data indicate that GS125 DBD mutation did not interfere with corepressor, coactivator, or RXR interactions, indicating that all of the important functional domains of this mutant TR, except DNA binding, are intact. A, gel mobility shift assays were performed with equimolar amounts of wild type and GS125 mutant TR-␤2 with RXR-␣ using radiolabeled DRϩ4 derivatives in which the downstream half-site was substituted with the corresponding nucleotide of consensus GRE half-sites as illustrated in B. C, the hybrid TR/GRE 3-DRϩ4 was inserted upstream of TK109 promoter in pA3Luc as two copies. The resulting reporter construct was cotransfected into 293T cells with wild type, GS125 TR-␤, or pKCR2 with and without RXR-␣. Data were performed in triplicate and repeated twice. Results are presented as fold activities, as compared with basal expression, and are the mean Ϯ S.E.
DISCUSSION
In the present study, we characterized the DNA binding domain mutant GS125 TR-␤2, which has a two amino acid substitution within the P box (GSG for wild type EGG). GS125 TR-␤2 exhibited functional ligand binding and corepressor and coactivator binding properties similar to wild type TRs, except for its inability to bind to positive and negative TREs. The GS125 DBD mutant was defective in both ligand-induced transactivation on pTRE reporter genes and ligand-induced transrepression on the negatively regulated gene promoters, crucial in regulating the H-P-T axis.
Negative feedback regulation of the H-P-T axis has been well studied because of its physiological importance. A number of reports have identified the element responsible for negative regulation and proposed mechanisms and target cofactors based on the traditional "on-DNA" hypothesis. The negative TRE within the human TSH-␤ genes is composed of single half-site motifs present near the TATA box and downstream of the transcription start site, which interact with the TR monomer (21, 22) . The human TRH promoter contains three nTREs, including separate half-sites which are responsible for T 3 -dependent negative regulation and binding of TR. Site 4 in the TRH gene, which is capable of binding not only TR monomers but also TR homodimers and TR-RXR heterodimers, may mediate the enhancement of negative regulation by the RXR (13) .
On the contrary, an "off-DNA" hypothesis for negative regulation was proposed by Tagami et al. (49) . They suggested that the DNA-binding domain of TR-␤ and/or direct DNA binding of TR was not necessary in TR-mediated control of negatively regulated genes. A question was raised, therefore, about whether negative TREs truly existed. These investigators utilized a DBD mutant, however, which would be predicted to disrupt the overall structure of the DBD, making its effect on gene regulation difficult to interpret. In this study, the GS125 DBD mutant provides a strong argument in support of the on-DNA hypothesis even on the TSH-␣ promoter. Clearly, by using this mutant, DNA binding by TR-␤ on negatively regulated gene is essential for the T 3 -mediated transcriptional regulation.
Because nTREs do not contain high affinity TR DNA-binding sites when tested by gel-shift analysis, it has been suggested that these regions might function as a composite site involving the receptor and other transcriptional cofactors. A newer model suggested that T 3 induced recruitment of TR and histone deacetylase to the TSH-␤ nTRE resulting in negative regulation in GH 3 cells (50) . This group suggested that TRs interacted directly with HDAC2 through the DNA-binding domain on the negative TRE of the TSH-␤ promoter. We employed an avidinbiotin complex DNA binding assay (ABCD assay) using biotinylated oligonucleotides to test the effect of ligand on DNA binding to the same nTRE. We succeeded in detecting direct DNA binding of TR-␤ in GH 3 nuclear extracts to the nTRE from human TSH-␤ gene using Western blot analysis and a TR-␤-specific antibody; T 3 had no effect on the extent of TR-␤ binding. DNA binding was abolished on a mutant human TSH-␤ fragment, indicating that binding was specific to the TSH-␤ nTRE (Fig. 3A) . These results are in accordance with other studies in which DNA binding is required for TR-␤-mediated negative regulation. We found no evidence to support a T 3 -mediated recruitment of TR to the TSH-␤ nTRE.
A number of studies have reported the effects of P box substitutions on TR DNA binding or the responsiveness of TRs on thyroid hormone-response elements (51) (52) (53) (54) (55) (56) . However, previously described DBD mutants would be predicted to disrupt the overall ␣-helical structure of the DBD or other functional domain structures. With these DBD mutants, it is difficult to conclude that loss of transcriptional activities is specifically caused by the lack of DNA binding versus other changes in the receptor. In this paper, the GS125 mutation was a P box mutation substituting GSG for the wild type EGG sequence found in TR. This unique DBD mutant TR-␤, which was predicted to bind to a GRE half-site, was able to bind to the hybrid TR/GRresponse element and was fully functional on this composite DNA element as a T 3 -responsive nuclear receptor. T 3 -dependent transactivation of GS125 TR-␤ on the hybrid TR/GR-response element was dramatically increased in the presence of RXR-␣ (Fig. 6 ). These data indicate that DNA binding of GS125 TR-␤ was RXR-dependent in this particular GR/TR composite response element. Finally, the GS125 mutant preserved interactions with transcriptional cofactors as shown in the mammalian two-hybrid assays. These results also support the conclusion that the GS125 mutant TR is a fully functional nuclear hormone receptor.
TRs are encoded by two distinctive genes, c-erbA-␣ and -␤ (57, 58) . Multiple isoforms of TRs are generated from two genes, and their expressions are regulated in specific temporal and spatial patterns (27) . TR-␤2 has tissue-specific expression in the anterior pituitary gland and the specific areas of the hypothalamus as well as brain and inner ear (7, 46, 59) . It has known that TR-␤2 isoforms play a key role in the feedback regulation of H-P-T axis (43, 44) . It is possible that GS125 DBD mutants TR-␤ might have various phenotypes in tissue-specific pattern in the in vivo study. For example, it was reported that DNA binding of the GR was necessary for some but not all feedback effects in the hypothalamic-pituitary-adrenal axis (60) .
In summary, DNA binding of TR-␤ is required for thyroid hormone-mediated transcriptional regulation of both positively and negatively regulated genes. The GS125 DNA-binding mutant establishes the importance of DNA binding in negative regulation of gene transcription mediated by thyroid hormone receptors.
